GLP-1 Drugs: The Strongest Path to Lasting Weight Loss & Improvement in Related Health Conditions September 12, 2025 By: Janet Klein, MS, RDN, CDN, CDCES Categories: Bariatric, Blog, Health & Wellness Janet Klein, MS RDN, CDN, CDCES, Bariatric Surgery and Obesity Medicine Program Director It may not be much of a surprise to hear that with the increased use of GLP-1s for weight loss, there has been a noted decline in patients undergoing bariatric surgery
End Stage Renal Disease (ESRD) patients on maintenance hemodialysis may have low plasma carnitine concentrations and an increased ratio of acylcarnitine/carnitine because of reduced intake of meat and dairy products, reduced renal synthesis and dialytic losses
Also, The National Institutes of Health and the Institute of Medicine have determined that no adverse effects have been established from excess amounts of B-12 in the body
Studies show weight loss varies by individual, but many patients lose 1 to 2 pounds per week on semaglutide
The standard advice is to use vitamin C in the morning and copper peptides in the evening, then alternate copper peptides with retinol on different nights, or use them in the same evening routine with copper peptides applied first